Trade Mark Journal No.2025/047 21 November 2025

UK00004292295 10 November 2025 (9,41,44)

Bconnected

Class 9: Electronic publications relating to breast cancer and the treatment thereof; downloadable applications for use in the management and treatment of breast cancer; downloadable applications for providing and tracking information relating to the management and treatment of breast cancer.
Class 41: Educational and training services relating to breast cancer; educational services related to a patient support programme in the field of breast cancer; providing educational information in the field of breast cancer; conducting educational support programmes for patients and health care practitioners relating to breast cancer; training for patients and healthcare practitioners in the organisation of support groups for patients with breast cancer; conducting classes, seminars and workshops in the field of breast cancer; providing online non-downloadable publications in the nature of articles, books and journals in the field of breast cancer.
Class 44: Medical and health care services relating to breast cancer; providing healthcare information to patients and health care practitioners in the field of breast cancer; providing medical information about breast cancer and the treatment thereof; providing medical support in the monitoring of patients receiving medical treatment for breast cancer; medical care and analysis services relating to the treatment of breast cancer.

Novartis Pharma AG

Representative: Abel & Imray LLP